Pivekimab MedChemExpress (MCE)

Product Name	Pivekimab
Synonyms	Pivekimab
CAS	2234335-84-1
EINECS
Chemical Formula
Molecular Weight
inchi
Package	1 mg;5 mg
Price	Email to quote
Descriptions	Pivekimab Pivekimab MedChemExpress (MCE) HY-P99234 2234335-84-1 96.12% Please store the product under the recommended conditions in the Certificate of Analysis. Shipping with dry ice. Pivekimab is a human IgG1 monoclonal antibody that targets interleukin-3 (IL-3) and CD123. Pivekimab is used to synthesize pivekimab sunirine, a CD123-directed antibody-active molecule conjugate (ADC). Pivekimab is used in the study of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Pivekimab can be utilized in the synthesis of pivekimab sunirine, a CD123-targeting antibody-drug conjugate (ADC) comprising Pivekimab, cleavable linker, and an indolinobenzodiazepine pseudodimer payload[1]. Chimeric Descriptions Pivekimab Pivekimab MedChemExpress (MCE) HY-P99234 2234335-84-1 96.12% Please store the product under the recommended conditions in the Certificate of Analysis. Shipping with dry ice. Pivekimab is a human IgG1 monoclonal antibody that targets interleukin-3 (IL-3) and CD123. Pivekimab is used to synthesize pivekimab sunirine, a CD123-directed antibody-active molecule conjugate (ADC). Pivekimab is used in the study of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Pivekimab can be utilized in the synthesis of pivekimab sunirine, a CD123-targeting antibody-drug conjugate (ADC) comprising Pivekimab, cleavable linker, and an indolinobenzodiazepine pseudodimer payload[1]. Chimeric Humanized Human IgG1 kappa Human IgG1 kappa, Isotype Control \| \| \| \| \| \| \| \| \| \| [1]. Patrick ZM, et, al. Methods of treatment using anti-CD123 immunoconjugates. WO2020092533. [2]. Poussard, et al. Spatial Response to Pivekimab Sunirine (IMGN632) In Vivo in a BPDCN Model. Blood 142 (2023): 2791.
Last Update	2025-04-01 14:45:47

MedChemExpress (MCE) also provides

Depatuxizumab

Category: Inhibitory Antibodies
CAS: 1471999-69-5
Last Update: 2025-04-01 14:45:47

Raxibacumab

Category: Inhibitory Antibodies
CAS: 565451-13-0
Last Update: 2025-04-01 14:45:47

Crizanlizumab

Category: Inhibitory Antibodies
CAS: 1690318-25-2
Last Update: 2025-04-01 14:45:47

Sofituzumab vedotin

Category: Inhibitory Antibodies
CAS: 1418200-58-4
Last Update: 2025-04-01 14:45:47

Fazpilodemab

Category: Inhibitory Antibodies
CAS: 2517935-02-1
Last Update: 2025-04-01 14:45:47

Osemitamab

Category: Inhibitory Antibodies
CAS: 2460539-61-9
Last Update: 2025-04-01 14:45:47

Visugromab

Category: Inhibitory Antibodies
CAS: 2556646-63-8
Last Update: 2025-04-01 14:45:47

Vobramitamab

Category: Inhibitory Antibodies
CAS: 2490556-50-6
Last Update: 2025-04-01 14:45:47


Supplier Name	MedChemExpress (MCE)
Contact	sales
Tel	609-228-6898
Mobile	609-228-6898
QQ
Email	sales@medchemexpress.com; tech@medchemexpress.com
Website	https://www.medchemexpress.com/
Wechat

Request for quotation

Supplier Contact